Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-30 Kaseta Michael Director Grant or award +53,960 53,960
2026-01-30 Duarte Ira EVP, Chief Financial Officer Grant or award · Restricted Stock Units +216,562 216,562
2026-01-30 Duarte Ira EVP, Chief Financial Officer Grant or award · Performance Stock Units +216,561 216,561
2026-01-30 Johnson Craig A Director Grant or award +53,960 53,960
2026-01-30 Cusack Thomas Director Grant or award +53,960 53,960
2026-01-30 Forbes William P EVP, Chief Development Officer Grant or award · Restricted Stock Units +188,315 188,315
2026-01-30 Forbes William P EVP, Chief Development Officer Grant or award · Performance Stock Units +188,314 188,314
2026-01-30 Dissanaike Sharmila Director Grant or award +53,960 53,960
2026-01-30 Hensley Mark Earl Chief Operating Officer Grant or award · Restricted Stock Units +188,315 188,315
2026-01-30 Hensley Mark Earl Chief Operating Officer Grant or award · Performance Stock Units +188,314 188,314
2026-01-30 Morgan Adam Director Grant or award +53,960 123,737
2026-01-19 Forbes William P EVP, Chief Development Officer Option exercise +3,875 170,078
2026-01-19 Forbes William P EVP, Chief Development Officer Option exercise · Restricted Stock Units −3,875 30,994
2026-01-19 Duarte Ira EVP, Chief Financial Officer Option exercise +3,875 183,661
2026-01-19 Duarte Ira EVP, Chief Financial Officer Option exercise · Restricted Stock Units −3,875 30,994
2026-01-19 Collard Craig A Chief Executive Officer Option exercise +13,797 536,921
2026-01-19 Collard Craig A Chief Executive Officer Option exercise · Restricted Stock Units −13,797 110,375
2025-11-08 Cusack Thomas Director Grant or award +37,879 37,879
2025-11-08 Cusack Thomas Director Grant or award · Stock Option (Right to Buy) +227,272 $1.10 $250K 227,272
2025-10-31 Forbes William P EVP, Chief Development Officer Option exercise +11,694 166,203

Page 6 of 28 · 557 trades